Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats.

Yale, J F; Lachance, D; Bevan, A P; Vigeant, C; Shaver, A; Posner, B I

Yale, J F; Lachance, D; Bevan, A P; Vigeant, C; Shaver, A; Posner, B I.

Affiliation

Yale JF; McGill Nutrition and Food Science Centre, McGill University, Montreal, Quebec, Canada.

Diabetes ; 44(11): 1274-9, 1995 Nov.

Article in En | MEDLINE | ID: mdl-7589823

Subject(s)

Blood Glucose/metabolism; Diabetes Mellitus, Type 1/drug therapy; Hypoglycemic Agents/pharmacology; Insulin/pharmacology; Vanadates/pharmacology; Animals; Blood Glucose/drug effects; Diabetes Mellitus, Type 1/blood; Drug Synergism; Female; Hypoglycemic Agents/administration & dosage; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Species Specificity; Structure-Activity Relationship; Time Factors; Vanadates/administration & dosage; Vanadium Compounds/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Vanadates / Diabetes Mellitus, Type 1 / Hypoglycemic Agents / Insulin Limits: Animals Language: En Journal: Diabetes Year: 1995 Document type: Article Affiliation country: Canada

Search on Google

Add to My VHL

XML

PubMed Links